Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1991-05-02
1992-08-04
Rollins, John W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
536 25, A61K 3170
Patent
active
051359189
ABSTRACT:
A method for achieving long term relief from the symptoms of atopic allergy, comprising parenteral administration of Vitamin B.sub.12 to selected patients, is produced. Vitamin B.sub.12 acts to reduce the levels of reaginic antibody (immunoglobulin) in these patients, and this effect persists beyond the period of treatment. The regimen may include oral administration of Vitamin B.sub.12 as well as other vitamins.
REFERENCES:
patent: 3160564 (1964-12-01), Hanus
patent: 3175948 (1965-03-01), Koff et al.
patent: 4806354 (1989-02-01), Green
The Pharmacological Basis of Therapeutics, 7th Ed., Goodman et al eds., MacMillan Publishing Co., New York, 1985, pp. 1325-1332.
Dewdney, "Prospects for modulation of the specific immune response in allergic diseases," Ch. 6 in Allergy and Asthma, A. B. Kay ed., Blackwell Scientific Publications, London, GB, 1989, pp. 91-98.
Katz, "Suppression of the IgE response with human proteins developed by biotechnology," Ch. 8 in Allergy and Asthma, A. B. Kay ed., Blackwell Scientific Publications, London, GB, 1989, pp. 113-125.
Hamberger, R. N. (1975) Science 189: 389.
Caruselli, M. (1952) RIF.MED. 66; 849-851 (informal English translation also attached).
Trampiz, G. (1959) Folia Clinica International, Jul.-Aug. 264-266 (informal English translation also attached).
Broncorp
Crane L. Eric
Rollins John W.
LandOfFree
Method for decreasing reaginic antibody levels does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for decreasing reaginic antibody levels, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for decreasing reaginic antibody levels will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-778406